title: Caspofungin for the treatment of immunocompromised and severely ill children and neonates with invasive fungal infections.
abstract: Caspofungin is the first member of the echinocandin class of antifungals to receive an indication for the use in infants, children, and adolescents from the United States Food and Drug Administration. Daily doses of 50 mg/m(2) result in pharmacokinetic parameters that are similar to those observed in adults. Although fewer data are available, the response rates in pediatric patients who received caspofungin either as treatment or empiric therapy in clinical trials are similar to those reported in adults. In addition, caspofungin appears to be generally safe and well tolerated in this population. This represents a significant step forward in the treatment of invasive fungal infections within this population, as caspofungin is associated with few clinically significant drug-interactions and toxicities compared to other antifungals, such as the azoles and amphotericin B.
authors: University of Texas at Austin College of Pharmacy, Austin, TX. ; University of Texas Health Science Center at San Antonio, San Antonio, TX.
authors: Nathan P
authors: NP
authors: Wiederhold
authors: Lydia A
authors: LA
authors: Herrera
keywords: aspergillosis; candidiasis; caspofungin; echinocandins; invasive fungal infections; neonates; pediatrics
references: Antimicrob Agents Chemother. 2009 Apr;53(4):1450-6
references: 19114680
references: Antimicrob Agents Chemother. 2002 Aug;46(8):2462-9
references: 12121919
references: Expert Rev Anti Infect Ther. 2011 Mar;9(3):275-8
references: 21417864
references: Clin Infect Dis. 2008 Sep 1;47(5):674-83
references: 18637757
references: Clin Infect Dis. 2005 Nov 1;41(9):1232-9
references: 16206095
references: J Bacteriol. 2001 Apr;183(7):2273-9
references: 11244067
references: Antimicrob Agents Chemother. 2011 May;55(5):2098-105
references: 21300834
references: Antimicrob Agents Chemother. 2009 Mar;53(3):869-75
references: 19075070
references: Antimicrob Agents Chemother. 2010 Dec;54(12):5042-7
references: 20837754
references: Pharmacotherapy. 2006 Jun;26(6):877-80
references: 16716141
references: Pediatr Infect Dis J. 2008 Sep;27(9):820-6
references: 18679151
references: Pediatrics. 2009 Mar;123(3):877-84
references: 19255017
references: Antimicrob Agents Chemother. 2008 Jul;52(7):2305-12
references: 18443110
references: Ann Pharmacother. 2012 Jan;46(1):108-16
references: 22190252
references: Mycoses. 2006 May;49(3):242-5
references: 16681818
references: J Clin Microbiol. 2012 Apr;50(4):1199-203
references: 22278842
references: Clin Infect Dis. 2009 Mar 1;48(5):503-35
references: 19191635
references: Pediatr Infect Dis J. 2006 Mar;25(3):282-3
references: 16511405
references: Pediatr Infect Dis J. 2009 Dec;28(12):1132-5
references: 19779392
references: Clin Infect Dis. 2004 Dec 1;39(11):1563-71
references: 15578352
references: Mycoses. 2011 May;54(3):234-42
references: 19906090
references: J Clin Microbiol. 2005 Nov;43(11):5425-7
references: 16272464
references: J Antimicrob Chemother. 2003 Jan;51(1):163-6
references: 12493803
references: Pediatr Infect Dis J. 2004 Dec;23(12):1093-7
references: 15626944
references: Antimicrob Agents Chemother. 2008 Feb;52(2):539-50
references: 18070979
references: J Clin Microbiol. 1998 Oct;36(10):2950-6
references: 9738049
references: Clin Infect Dis. 2006 Jul 1;43(1):25-31
references: 16758414
references: J Antimicrob Chemother. 2006 Apr;57(4):705-8
references: 16464893
references: Antimicrob Agents Chemother. 2007 Jun;51(6):2253-6
references: 17420211
references: Antimicrob Agents Chemother. 2005 Dec;49(12):5146-8
references: 16304189
references: J Clin Microbiol. 2006 Feb;44(2):324-6
references: 16455878
references: Diagn Microbiol Infect Dis. 1998 Sep;32(1):33-7
references: 9791755
references: Diagn Microbiol Infect Dis. 2003 Feb;45(2):131-5
references: 12614985
references: N Engl J Med. 2002 Dec 19;347(25):2020-9
references: 12490683
references: Clin Infect Dis. 2006 Apr 1;42(7):938-44
references: 16511756
references: Antimicrob Agents Chemother. 2006 Jun;50(6):2058-63
references: 16723566
references: Int J Antimicrob Agents. 2011 Jul;38(1):65-9
references: 21514797
references: J Clin Pharmacol. 2005 Aug;45(8):954-60
references: 16027407
references: Antimicrob Agents Chemother. 2006 Sep;50(9):3160-1
references: 16940118
references: J Clin Microbiol. 2006 Mar;44(3):760-3
references: 16517851
references: Antimicrob Agents Chemother. 2005 Nov;49(11):4536-45
references: 16251293
references: J Perinatol. 2005 Dec;25(12):770-7
references: 16222348
references: Antimicrob Agents Chemother. 2004 Apr;48(4):1382-3
references: 15047549
references: Antimicrob Agents Chemother. 2005 Dec;49(12):5058-68
references: 16304173
references: Diagn Microbiol Infect Dis. 1998 Apr;30(4):251-5
references: 9582584
references: N Engl J Med. 2004 Sep 30;351(14):1391-402
references: 15459300
references: Antimicrob Agents Chemother. 2011 May;55(5):2245-55
references: 21383097
references: Antimicrob Agents Chemother. 2002 Sep;46(9):3001-12
references: 12183260
references: Pediatrics. 1999 Dec;104(6):1327-33
references: 10585984
references: Antimicrob Agents Chemother. 2005 Aug;49(8):3264-73
references: 16048935
references: Clin Infect Dis. 2001 Nov 1;33(9):1529-35
references: 11588698
references: J Infect Dis. 2004 Oct 15;190(8):1464-71
references: 15378439
references: Med Mycol. 2005 Sep;43(6):559-64
references: 16320498
references: J Clin Microbiol. 2003 Dec;41(12):5729-31
references: 14662968
references: Antimicrob Agents Chemother. 1997 Nov;41(11):2471-9
references: 9371352
references: Antimicrob Agents Chemother. 2002 Feb;46(2):451-7
references: 11796357
references: Diagn Microbiol Infect Dis. 1999 Sep;35(1):19-25
references: 10529877
references: Antimicrob Agents Chemother. 2005 Feb;49(2):767-9
references: 15673762
references: Antimicrob Agents Chemother. 2005 Sep;49(9):3640-5
references: 16127033
references: Hepatology. 2000 Jul;32(1):82-6
references: 10869292
references: Antimicrob Agents Chemother. 2004 Nov;48(11):4306-14
references: 15504857
references: Drug Metab Dispos. 2005 May;33(5):676-82
references: 15716364
references: Ann Pharmacother. 2010 Jan;44(1):166-77
references: 20009006
references: Pediatr Infect Dis J. 2010 May;29(5):415-20
references: 20431381
references: Diagn Microbiol Infect Dis. 2002 May;43(1):13-7
references: 12052624
references: Antimicrob Agents Chemother. 2006 Jul;50(7):2522-4
references: 16801435
references: Antimicrob Agents Chemother. 2003 Apr;47(4):1376-81
references: 12654673
references: J Acquir Immune Defic Syndr. 2002 Oct 1;31(2):183-7
references: 12394797
references: Transpl Infect Dis. 2002 Mar;4(1):25-30
references: 12123423
references: Chemotherapy. 2002 May;48(2):78-81
references: 12011539
references: Clin Infect Dis. 2004 Aug 1;39(3):309-17
references: 15306996
references: Clin Infect Dis. 2003 Sep 1;37(5):634-43
references: 12942393
references: Curr Opin Infect Dis. 2011 Jun;24(3):225-9
references: 21455060
references: AIDS Res Hum Retroviruses. 2002 Sep 1;18(13):903-8
references: 12230933
references: Antimicrob Agents Chemother. 2003 Jun;47(6):1995-8
references: 12760883
references: Antimicrob Agents Chemother. 2007 May;51(5):1616-20
references: 17307976
references: Clin Microbiol Infect. 2010 Sep;16(9):1321-7
references: 20840541
references: J Clin Pharmacol. 2005 Sep;45(9):1018-24
references: 16100295
references: Drug Resist Updat. 2011 Jun;14(3):164-76
references: 21353623
references: Antimicrob Agents Chemother. 2006 Jul;50(7):2569-72
references: 16801448
references: J Antimicrob Chemother. 2002 Jul;50(1):119-23
references: 12096017